Corrine Hanson1, Elizabeth Lyden2, Jeremy Furtado3, Hannia Campos3, David Sparrow4, Pantel Vokonas4, Augusto A Litonjua5. 1. University of Nebraska Medical Center, School of Allied Health Professions, Medical Nutrition Education, 984045 Nebraska Medical Center, Omaha, NE 68198-4045, USA. Electronic address: ckhanson@unmc.edu. 2. University of Nebraska Medical Center, College of Public Health, 984375 Nebraska Medical Center, Omaha, NE 68198-4375, USA. 3. Department of Nutrition, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA 02215, USA. 4. Veterans Affairs Boston Healthcare System and Department of Medicine, Boston University School of Medicine, Boston, MA 02130, USA. 5. Channing Laboratory and Pulmonary and Critical Care Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, USA.
Abstract
BACKGROUND & AIMS: The results of studies assessing relationships between vitamin E intake and status and lung function are conflicting. This study aimed to evaluate the effect of vitamin E intake and serum levels of tocopherol isoforms on lung function in a cross-sectional sample of 580 men from the Normative Aging Study, a longitudinal aging study. METHODS: Regression models were used to look at associations of serum tocopherol isoform levels and vitamin E intake with lung function parameters after adjustment for confounders. Vitamin E intake was measured using a food frequency questionnaire and serum levels of γ, α, and δ-tocopherol levels were measured using high-performance liquid chromatography. RESULTS: After adjustment for potential confounders, serum γ-tocopherol had a significant inverse association with forced vital capacity (β = -0.10, p = 0.05). Alpha and δ-tocopherol were not associated with any lung function parameter. After classifying COPD status according to Global Initiative for Obstructive Lung Disease (GOLD) stage criteria, serum levels of δ-tocopherol were lower in participants with more severe COPD (p = 0.01). Serum levels of δ-tocopherol were also lower in participants with greater levels of smoking (p = 0.02). Both vitamin E intake (β = 0.03, p = 0.02; β = 0.03, p = 0.01) and use of vitamin E supplements (β = 0.05, p = 0.03; β = 0.06. p = 0.02) were positively associated with FEV1 and FVC, after adjusting for confounders. Subjects who took vitamin E supplements had significantly higher α-tocopherol levels (p < 0.0001) and lower γ-tocopherol levels (p < 0.0001) than non-users. CONCLUSION: In this study, there is a positive association between dietary vitamin E intake and lung function, and evidence of an inverse relationship between serum levels of γ-tocopherol and lung function.
BACKGROUND & AIMS: The results of studies assessing relationships between vitamin E intake and status and lung function are conflicting. This study aimed to evaluate the effect of vitamin E intake and serum levels of tocopherol isoforms on lung function in a cross-sectional sample of 580 men from the Normative Aging Study, a longitudinal aging study. METHODS: Regression models were used to look at associations of serum tocopherol isoform levels and vitamin E intake with lung function parameters after adjustment for confounders. Vitamin E intake was measured using a food frequency questionnaire and serum levels of γ, α, and δ-tocopherol levels were measured using high-performance liquid chromatography. RESULTS: After adjustment for potential confounders, serum γ-tocopherol had a significant inverse association with forced vital capacity (β = -0.10, p = 0.05). Alpha and δ-tocopherol were not associated with any lung function parameter. After classifying COPD status according to Global Initiative for Obstructive Lung Disease (GOLD) stage criteria, serum levels of δ-tocopherol were lower in participants with more severe COPD (p = 0.01). Serum levels of δ-tocopherol were also lower in participants with greater levels of smoking (p = 0.02). Both vitamin E intake (β = 0.03, p = 0.02; β = 0.03, p = 0.01) and use of vitamin E supplements (β = 0.05, p = 0.03; β = 0.06. p = 0.02) were positively associated with FEV1 and FVC, after adjusting for confounders. Subjects who took vitamin E supplements had significantly higher α-tocopherol levels (p < 0.0001) and lower γ-tocopherol levels (p < 0.0001) than non-users. CONCLUSION: In this study, there is a positive association between dietary vitamin E intake and lung function, and evidence of an inverse relationship between serum levels of γ-tocopherol and lung function.
Authors: Paivi M Salo; Angelico Mendy; Jesse Wilkerson; Samantha A Molsberry; Lydia Feinstein; Stephanie J London; Michael B Fessler; Peter S Thorne; Darryl C Zeldin Journal: Respir Res Date: 2022-06-09
Authors: Jiayi Xu; Kristin A Guertin; Nathan C Gaddis; Anne H Agler; Robert S Parker; Jared M Feldman; Alan R Kristal; Kathryn B Arnold; Phyllis J Goodman; Catherine M Tangen; Dana B Hancock; Patricia A Cassano Journal: Am J Clin Nutr Date: 2022-04-01 Impact factor: 7.045
Authors: Cosby A Stone; Joan Cook-Mills; Tebeb Gebretsadik; Christian Rosas-Salazar; Kedir Turi; Steven M Brunwasser; Alexandra Connolly; Patty Russell; Zhouwen Liu; Kaitlin Costello; Tina V Hartert Journal: J Pediatr Date: 2018-12-05 Impact factor: 6.314
Authors: Vanessa Garcia-Larsen; James F Potts; Ernst Omenaas; Joachim Heinrich; Cecilie Svanes; Judith Garcia-Aymerich; Peter G Burney; Deborah L Jarvis Journal: Eur Respir J Date: 2017-12-21 Impact factor: 16.671
Authors: Amar J Mehta; Aedín Cassidy; Augusto A Litonjua; David Sparrow; Pantel Vokonas; Joel Schwartz Journal: Am J Clin Nutr Date: 2016-01-20 Impact factor: 7.045